Department of Radiology
Jason S. Lewis has not added Biography.
If you are Jason S. Lewis and would like to personalize this page please email our Author Liaison for assistance.
Copper-64-pyruvaldehyde-bis(N(4)-methylthiosemicarbazone) for the prevention of tumor growth at wound sites following laparoscopic surgery: monitoring therapy response with microPET and magnetic resonance imaging.
Cancer research Jan, 2002 | Pubmed ID: 11809694
Copper bis(thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships.
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry Mar, 2002 | Pubmed ID: 11935349
DOTA-D-Tyr(1)-octreotate: a somatostatin analogue for labeling with metal and halogen radionuclides for cancer imaging and therapy.
Bioconjugate chemistry Jul-Aug, 2002 | Pubmed ID: 12121126
Small animal imaging. current technology and perspectives for oncological imaging.
European journal of cancer (Oxford, England : 1990) Nov, 2002 | Pubmed ID: 12387842
Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone).
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Nov, 2002 | Pubmed ID: 12411560
Molecular imaging: the application of small animal positron emission tomography.
Journal of cellular biochemistry. Supplement , 2002 | Pubmed ID: 12552610
Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60Cu-ATSM: relationship to therapeutic response-a preliminary report.
International journal of radiation oncology, biology, physics Apr, 2003 | Pubmed ID: 12654432
In vivo assessment of tumor hypoxia in lung cancer with 60Cu-ATSM.
European journal of nuclear medicine and molecular imaging Jun, 2003 | Pubmed ID: 12692685
Intra-tumoral distribution of (64)Cu-ATSM: a comparison study with FDG.
Nuclear medicine and biology Jul, 2003 | Pubmed ID: 12831991
[Tc(CO)(3)](+) chemistry: a promising new concept for SPECT? Against.
European journal of nuclear medicine and molecular imaging Sep, 2003 | Pubmed ID: 12898205
Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals.
Nuclear medicine and biology Oct, 2003 | Pubmed ID: 14499330
Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.
Cancer research Sep, 2003 | Pubmed ID: 14500386
Basic characterization of 64Cu-ATSM as a radiotherapy agent.
Nuclear medicine and biology Jan, 2005 | Pubmed ID: 15691658
Investigation into 64Cu-labeled Bis(selenosemicarbazone) and Bis(thiosemicarbazone) complexes as hypoxia imaging agents.
Nuclear medicine and biology Feb, 2005 | Pubmed ID: 15721760
Dosimetry of 60/61/62/64Cu-ATSM: a hypoxia imaging agent for PET.
European journal of nuclear medicine and molecular imaging Jul, 2005 | Pubmed ID: 15785955
Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models.
International journal of radiation oncology, biology, physics Apr, 2005 | Pubmed ID: 15817355
Imaging of melanoma using 64Cu- and 86Y-DOTA-ReCCMSH(Arg11), a cyclized peptide analogue of alpha-MSH.
Journal of medicinal chemistry Apr, 2005 | Pubmed ID: 15828837
Positron-emitting isotopes produced on biomedical cyclotrons.
Current medicinal chemistry , 2005 | Pubmed ID: 15853713
A tat fusion protein-based tumor vaccine for breast cancer.
Annals of surgical oncology Jul, 2005 | Pubmed ID: 15889213
Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSM.
Nuclear medicine and biology Aug, 2005 | Pubmed ID: 16026709
Identification of a novel prostate tumor target, mindin/RG-1, for antibody-based radiotherapy of prostate cancer.
Cancer research Sep, 2005 | Pubmed ID: 16166318
Measurement of input functions in rodents: challenges and solutions.
Nuclear medicine and biology Oct, 2005 | Pubmed ID: 16243642
Preparation of high specific activity (86)Y using a small biomedical cyclotron.
Nuclear medicine and biology Nov, 2005 | Pubmed ID: 16253815
Minimally invasive method of determining blood input function from PET images in rodents.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Feb, 2006 | Pubmed ID: 16455640
Assessment of myocardial blood flow using 15O-water and 1-11C-acetate in rats with small-animal PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Mar, 2006 | Pubmed ID: 16513617
In vivo skeletal imaging of 18F-fluoride with positron emission tomography reveals damage- and time-dependent responses to fatigue loading in the rat ulna.
Bone Aug, 2006 | Pubmed ID: 16533624
Three-dimensional maximum a posteriori (MAP) imaging with radiopharmaceuticals labeled with three Cu radionuclides.
Nuclear medicine and biology Feb, 2006 | Pubmed ID: 16546676
Assessment of myocardial metabolism in diabetic rats using small-animal PET: a feasibility study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Apr, 2006 | Pubmed ID: 16595504
Validation of a novel CHX-A'' derivative suitable for peptide conjugation: small animal PET/CT imaging using yttrium-86-CHX-A''-octreotide.
Journal of medicinal chemistry Jul, 2006 | Pubmed ID: 16821789
Imaging oxygenation of human tumours.
European radiology Apr, 2007 | Pubmed ID: 17043737
Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy.
International journal of radiation biology Oct, 2006 | Pubmed ID: 17118889
64Cu-azabicyclo[3.2.2]nonane thiosemicarbazone complexes: radiopharmaceuticals for PET of topoisomerase II expression in tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Dec, 2006 | Pubmed ID: 17138747
Synthesis and biologic evaluation of 64Cu-labeled rhenium-cyclized alpha-MSH peptide analog using a cross-bridged cyclam chelator.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Jan, 2007 | Pubmed ID: 17204700
In vivo imaging in a murine model of glioblastoma.
Neurosurgery Feb, 2007 | Pubmed ID: 17290188
Molecular imaging of gastrin-releasing peptide receptor-positive tumors in mice using 64Cu- and 86Y-DOTA-(Pro1,Tyr4)-bombesin(1-14).
Bioconjugate chemistry May-Jun, 2007 | Pubmed ID: 17378600
Cu-ATSM: a radiopharmaceutical for the PET imaging of hypoxia.
Dalton transactions (Cambridge, England : 2003) Nov, 2007 | Pubmed ID: 17992274
Gallium-68-labeled DOTA-rhenium-cyclized alpha-melanocyte-stimulating hormone analog for imaging of malignant melanoma.
Nuclear medicine and biology Nov, 2007 | Pubmed ID: 17998097
Synthesis, in vitro and in vivo characterization of (64)Cu(I) complexes derived from hydrophilic tris(hydroxymethyl)phosphane and 1,3,5-triaza-7-phosphaadamantane ligands.
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry Feb, 2008 | Pubmed ID: 18043951
Assessing tumor hypoxia in cervical cancer by PET with 60Cu-labeled diacetyl-bis(N4-methylthiosemicarbazone).
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Feb, 2008 | Pubmed ID: 18199612
1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Feb, 2008 | Pubmed ID: 18199615
Examining the relationship between Cu-ATSM hypoxia selectivity and fatty acid synthase expression in human prostate cancer cell lines.
Nuclear medicine and biology Apr, 2008 | Pubmed ID: 18355682
In vitro and in vivo evaluation of bifunctional bisthiosemicarbazone 64Cu-complexes for the positron emission tomography imaging of hypoxia.
Journal of medicinal chemistry May, 2008 | Pubmed ID: 18416544
An imaging comparison of 64Cu-ATSM and 60Cu-ATSM in cancer of the uterine cervix.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Jul, 2008 | Pubmed ID: 18552145
Radiometal-labeled somatostatin analogs for applications in cancer imaging and therapy.
Methods in molecular biology (Clifton, N.J.) , 2007 | Pubmed ID: 18604948
Evaluation of a bromine-76-labeled progestin 16alpha,17alpha-dioxolane for breast tumor imaging and radiotherapy: in vivo biodistribution and metabolic stability studies.
Nuclear medicine and biology Aug, 2008 | Pubmed ID: 18678350
Autoradiographic and small-animal PET comparisons between (18)F-FMISO, (18)F-FDG, (18)F-FLT and the hypoxic selective (64)Cu-ATSM in a rodent model of cancer.
Nuclear medicine and biology Aug, 2008 | Pubmed ID: 18678357
Tumor hypoxia detected by positron emission tomography with 60Cu-ATSM as a predictor of response and survival in patients undergoing Neoadjuvant chemoradiotherapy for rectal carcinoma: a pilot study.
Diseases of the colon and rectum Nov, 2008 | Pubmed ID: 18682881
Synthesis and characterization of the copper(II) complexes of new N2S2-donor macrocyclic ligands: synthesis and in vivo evaluation of the (64)Cu complexes.
Dalton transactions (Cambridge, England : 2003) Jan, 2009 | Pubmed ID: 19081987
In vivo biodistribution, PET imaging, and tumor accumulation of 86Y- and 111In-antimindin/RG-1, engineered antibody fragments in LNCaP tumor-bearing nude mice.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Mar, 2009 | Pubmed ID: 19223400
Bromination from the macroscopic level to the tracer radiochemical level: (76)Br radiolabeling of aromatic compounds via electrophilic substitution.
Bioconjugate chemistry Apr, 2009 | Pubmed ID: 19260733
(64)Cu-labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity.
Nuclear medicine and biology Apr, 2009 | Pubmed ID: 19324273
Radiopharmaceuticals in preclinical and clinical development for monitoring of therapy with PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine May, 2009 | Pubmed ID: 19380404
A novel technology for the imaging of acidic prostate tumors by positron emission tomography.
Cancer research May, 2009 | Pubmed ID: 19417132
Melanoma imaging using (111)In-, (86)Y- and (68)Ga-labeled CHX-A''-Re(Arg11)CCMSH.
Nuclear medicine and biology May, 2009 | Pubmed ID: 19423001
Standardized methods for the production of high specific-activity zirconium-89.
Nuclear medicine and biology Oct, 2009 | Pubmed ID: 19720285
Nitroimidazole conjugates of bis(thiosemicarbazonato)64Cu(II) - Potential combination agents for the PET imaging of hypoxia.
Journal of inorganic biochemistry Feb, 2010 | Pubmed ID: 19932509
Measuring the pharmacodynamic effects of a novel Hsp90 inhibitor on HER2/neu expression in mice using Zr-DFO-trastuzumab.
PloS one , 2010 | Pubmed ID: 20111600
Unconventional nuclides for radiopharmaceuticals.
Molecular imaging Feb, 2010 | Pubmed ID: 20128994
Clickable bifunctional radiometal chelates for peptide labeling.
Chemical communications (Cambridge, England) Mar, 2010 | Pubmed ID: 20177623
Improved synthesis of 2'-deoxy-2'-[18F]-fluoro-1-beta-D-arabinofuranosyl-5-iodouracil ([18F]-FIAU).
Nuclear medicine and biology May, 2010 | Pubmed ID: 20447555
Cerenkov luminescence imaging of medical isotopes.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Jul, 2010 | Pubmed ID: 20554722
89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Aug, 2010 | Pubmed ID: 20660376
Imaging and treating tumor vasculature with targeted radiolabeled carbon nanotubes.
International journal of nanomedicine , 2010 | Pubmed ID: 21042424
Role of metalation in the topoisomerase IIα inhibition and antiproliferation activity of a series of α-heterocyclic-N4-substituted thiosemicarbazones and their Cu(II) complexes.
Journal of medicinal chemistry Apr, 2011 | Pubmed ID: 21391686
Magnitude of enhanced permeability and retention effect in tumors with different phenotypes: 89Zr-albumin as a model system.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Apr, 2011 | Pubmed ID: 21421727
A practical guide to the construction of radiometallated bioconjugates for positron emission tomography.
Dalton transactions (Cambridge, England : 2003) Jun, 2011 | Pubmed ID: 21442098
Intraoperative imaging of positron emission tomographic radiotracers using Cerenkov luminescence emissions.
Molecular imaging Jun, 2011 | Pubmed ID: 21496448
The next generation of positron emission tomography radiopharmaceuticals in oncology.
Seminars in nuclear medicine Jul, 2011 | Pubmed ID: 21624561
The synthesis and evaluation of N1-(4-(2-[18F]-fluoroethyl)phenyl)-N8-hydroxyoctanediamide ([18F]-FESAHA), a PET radiotracer designed for the delineation of histone deacetylase expression in cancer.
Nuclear medicine and biology Jul, 2011 | Pubmed ID: 21718944
Modular strategy for the construction of radiometalated antibodies for positron emission tomography based on inverse electron demand Diels-Alder click chemistry.
Bioconjugate chemistry Oct, 2011 | Pubmed ID: 21877749
Targeting the internal epitope of prostate-specific membrane antigen with 89Zr-7E11 immuno-PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Oct, 2011 | Pubmed ID: 21908391
Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90.
Nature chemical biology Nov, 2011 | Pubmed ID: 21946277
89Zr-labeled dextran nanoparticles allow in vivo macrophage imaging.
Bioconjugate chemistry Dec, 2011 | Pubmed ID: 22035047
Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen.
Cancer discovery Apr, 2012 | Pubmed ID: 22576209
Efficient (18)F-labeling of large 37-amino-acid pHLIP peptide analogues and their biological evaluation.
Bioconjugate chemistry Aug, 2012 | Pubmed ID: 22784215
An improved strategy for the synthesis of [¹⁸F]-labeled arabinofuranosyl nucleosides.
Nuclear medicine and biology Nov, 2012 | Pubmed ID: 22819195
PET imaging with ⁸⁹Zr: from radiochemistry to the clinic.
Nuclear medicine and biology Jan, 2013 | Pubmed ID: 22998840
Annotating MYC status with 89Zr-transferrin imaging.
Nature medicine Oct, 2012 | Pubmed ID: 23001181
H(2)azapa: a versatile acyclic multifunctional chelator for (67)Ga, (64)Cu, (111)In, and (177)Lu.
Inorganic chemistry Nov, 2012 | Pubmed ID: 23106422
(89)Zr-Labeled Paramagnetic Octreotide-Liposomes for PET-MR Imaging of Cancer.
Pharmaceutical research Dec, 2012 | Pubmed ID: 23224977
Imaging Tumor Burden in the Brain with 89Zr-Transferrin.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Jan, 2013 | Pubmed ID: 23236019
Antilipolytic drug boosts glucose metabolism in prostate cancer.
Nuclear medicine and biology May, 2013 | Pubmed ID: 23454248
Monitoring afatinib treatment in HER2-positive gastric cancer with 18F-FDG and 89Zr-trastuzumab PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Jun, 2013 | Pubmed ID: 23578997
The growing impact of bioorthogonal click chemistry on the development of radiopharmaceuticals.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Jun, 2013 | Pubmed ID: 23616581
Enzyme-mediated methodology for the site-specific radiolabeling of antibodies based on catalyst-free click chemistry.
Bioconjugate chemistry Jun, 2013 | Pubmed ID: 23688208
A Pretargeted PET Imaging Strategy Based on Bioorthogonal Diels-Alder Click Chemistry.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Aug, 2013 | Pubmed ID: 23708196
Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcome.
PloS one , 2013 | Pubmed ID: 23741342
Sandmeyer reaction repurposed for the site-selective, non-oxidizing radioiodination of fully-deprotected peptides: studies on the endogenous opioid peptide α-neoendorphin.
Bioorganic & medicinal chemistry letters Aug, 2013 | Pubmed ID: 23796454
H(4)octapa-trastuzumab: versatile acyclic chelate system for 111In and 177Lu imaging and therapy.
Journal of the American Chemical Society Aug, 2013 | Pubmed ID: 23901833
Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Oct, 2013 | Pubmed ID: 23970364
Applying PET to broaden the diagnostic utility of the clinically validated CA19.9 serum biomarker for oncology.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Nov, 2013 | Pubmed ID: 24029655
H6phospa-trastuzumab: bifunctional methylenephosphonate-based chelator with 89Zr, 111In and 177Lu.
Dalton transactions (Cambridge, England : 2003) Jan, 2014 | Pubmed ID: 24104523
A prospective pilot study of (89)zr-j591/prostate specific membrane antigen positron emission tomography in men with localized prostate cancer undergoing radical prostatectomy.
The Journal of urology May, 2014 | Pubmed ID: 24135437
Synthesis and evaluation of 18F-labeled benzylguanidine analogs for targeting the human norepinephrine transporter.
European journal of nuclear medicine and molecular imaging Feb, 2014 | Pubmed ID: 24173571
(18)F-labeled-bioorthogonal liposomes for in vivo targeting.
Bioconjugate chemistry Nov, 2013 | Pubmed ID: 24180480
Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals.
Inorganic chemistry Feb, 2014 | Pubmed ID: 24313747
Influence of free fatty acids on glucose uptake in prostate cancer cells.
Nuclear medicine and biology Mar, 2014 | Pubmed ID: 24440212
Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG.
Clinical cancer research : an official journal of the American Association for Cancer Research Apr, 2014 | Pubmed ID: 24573553
Pairwise comparison of 89Zr- and 124I-labeled cG250 based on positron emission tomography imaging and nonlinear immunokinetic modeling: in vivo carbonic anhydrase IX receptor binding and internalization in mouse xenografts of clear-cell renal cell carcinoma.
European journal of nuclear medicine and molecular imaging May, 2014 | Pubmed ID: 24604591
Antagonism of EGFR and HER3 enhances the response to inhibitors of the PI3K-Akt pathway in triple-negative breast cancer.
Science signaling Mar, 2014 | Pubmed ID: 24667376
Noninvasive Imaging of PSMA in prostate tumors with (89)Zr-Labeled huJ591 engineered antibody fragments: the faster alternatives.
Molecular pharmaceutics Nov, 2014 | Pubmed ID: 24779727
Understanding the pharmacological properties of a metabolic PET tracer in prostate cancer.
Proceedings of the National Academy of Sciences of the United States of America May, 2014 | Pubmed ID: 24785505
Building Blocks for the Construction of Bioorthogonally Reactive Peptides via Solid-Phase Peptide Synthesis.
ChemistryOpen Apr, 2014 | Pubmed ID: 24808990
Alternative chelator for ⁸⁹Zr radiopharmaceuticals: radiolabeling and evaluation of 3,4,3-(LI-1,2-HOPO).
Journal of medicinal chemistry Jun, 2014 | Pubmed ID: 24814511
In vivo imaging of GLP-1R with a targeted bimodal PET/fluorescence imaging agent.
Bioconjugate chemistry Jul, 2014 | Pubmed ID: 24856928
Development of a minimal saponin vaccine adjuvant based on QS-21.
Nature chemistry Jul, 2014 | Pubmed ID: 24950335
Targeting breast tumors with pH (low) insertion peptides.
Molecular pharmaceutics Aug, 2014 | Pubmed ID: 25004202
A modular labeling strategy for in vivo PET and near-infrared fluorescence imaging of nanoparticle tumor targeting.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Oct, 2014 | Pubmed ID: 25060196
CDK9-mediated transcription elongation is required for MYC addiction in hepatocellular carcinoma.
Genes & development Aug, 2014 | Pubmed ID: 25128497
⁸⁹Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer.
European journal of nuclear medicine and molecular imaging Nov, 2014 | Pubmed ID: 25143071
What a difference a carbon makes: H₄octapa vs H₄C3octapa, ligands for In-111 and Lu-177 radiochemistry.
Inorganic chemistry Oct, 2014 | Pubmed ID: 25192223
Synthesis and evaluation of (18)F-labeled ATP competitive inhibitors of topoisomerase II as probes for imaging topoisomerase II expression.
European journal of medicinal chemistry Oct, 2014 | Pubmed ID: 25240701
Chemoenzymatic strategy for the synthesis of site-specifically labeled immunoconjugates for multimodal PET and optical imaging.
Bioconjugate chemistry Dec, 2014 | Pubmed ID: 25418333
Annotating STEAP1 regulation in prostate cancer with 89Zr immuno-PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine Dec, 2014 | Pubmed ID: 25453051
JoVE 소개
Copyright © 2024 MyJoVE Corporation. 판권 소유